The G2-M cell cycle checkpoint adjustment factor, WEE1, and the DNA damage response factor, TOPBP1, may be downregulated in BRCA-deficient ovarian cancer following treatment with BET inhibitor JQ1. Here, DNER is linked to ovarian carcinoma.